Pharma's Market
SPECIAL REPORT
MOST SHARED
- Zero China Growth Is ‘Probable’: Gordon Chang
- Marc Faber: 100% Chance of Global Recession
- Citigroup Lost $20 Million on Facebook IPO Trades
- China Growth Risks Signal Need for Fiscal Action
- Senate Summons Dimon to 'Get to the Bottom' of JPM Mess
- What College Tuition Will Look Like in 18 Years
- Romney Leads Poll Of Small Business Owners
- Greek Exit Could Trigger 50% Fall in Euro Stocks: Analyst
- Bacon Tourism: From the Davos of Bacon to Bacon Mecca
- A New Look at the ‘New Poor’
- Six Pack: Beer Buzz of the Week
- Greek Exit Could Trigger 50% Fall in Euro Stocks: Analyst
- Under Pressure, FHA Skews to Wealthier Home Buyers
- Big Stock Upside for Hudson City Deal: Analyst
- 5 High-Yield Stocks Ready to Boost Dividends
- Yoshikami: Four Things You Need to Know About Gold Now
- Steinbock: The Euro Zone Endgame Begins
- Option Bulls Take Another Shot on Idenix
- Citigroup Lost $20 Million on Facebook IPO Trades
- Sticker Shock: What College Is Likely to Cost in 18 Years
- JPMorgan to Shake Up Risk Team After Big Loss: Report
- Icahn Raises Stake in Chesapeake, Wants Board Seats
- Marc Faber: Chance of Global Recession Is Now 100%
- Week Ahead: Europe Has Wall Street Bull on Short Leash
- What Happened to Stocks? Most Unloved in 50 Years
- Cool Jobs: From Gold Stacker to Bed Tester
- Many Greeks Moved Their Money Abroad Long Ago
RSS FEED
A "Short" Story On Amgen
Text Size 
Reporter
 |
]. Right now it's 39th on Barron's list of the Top-40 largest short positions. To take a small step back, the short interest is a barometer of bearish investors in a stock. These are people (oftentimes hedge funds) who think shares are gonna go down and position themselves to make money if/when they do.
Anyway, this weekend one name on the list jumped out at me: Amgen. According to Barron's, the number of AMGN[AMGN
Loading...
()
] shares being shorted skyrocketed 114 percent from May 30th to June 13th. It more than doubled in two weeks! On the 30th nearly 23 million Amgen shares were being shorted and by the 13th more than 48 million shares were in the claws of the bears. That puts Amgen in 14th place among the Top-40 largest short positions, but it is number two on the list of largest changes in short positions behind Sun Microsystems[JAVA
Loading...
()
].
What's behind the pessimism? It could be that any day now the Food and Drug Administration could issue new restrictions on the use of Amgen's anemia drugs in cancer patients. An FDA Advisory Committee made recommendations to the agency about that last March. So, maybe a growing number of investors have a hunch the FDA could be more stringent than its panel of outside experts. And then, of course, there's the data expected later this year on Amgen's all-important osteoporosis drug D-mab. Or possibly something else I'm not aware of might be stoking the shorting.
Amgen reports its second quarter earnings July 28th after the closing bell.
Amgen, by the way, is one of the many biotech stocks FBR is suspending coverage of today "due to the departure of the analyst." That would be Jim Reddoch. I don't know the backstory yet.
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes
